中药与华法林相互作用:临床与研究进展
华法林治疗窗窄、个体剂量差异大,中药与其联用可致INR波动或出血。本文检索1990年1月1日至2021年5月1日PubMed、MEDLINE、Cochrane图书馆、Web of Science、CNKI及万方数据,纳入64篇文献(临床报告、药理实验及体外实验),总结中药影响华法林抗凝增强或减弱的机制,为临床安全合理用药提供参考。
要点
- 华法林与中药联用常见,可致INR波动或出血,临床需谨慎。
- 中药可通过多种机制增强或减弱华法林抗凝效果。
- 部分中药在体内外实验、药理与临床研究中结果不一致,需重点研究。
核心结论
- 中药与华法林联用常见,可经多种机制增强或减弱华法林抗凝效果,临床使用需谨慎。
- 本文旨在促进临床医生对与华法林相互作用中药的认识,避免不良临床治疗过程,提高疗效与安全性。
研究设计与样本
- 计算机检索PubMed、MEDLINE、Cochrane图书馆、Web of Science、CNKI及万方数据,时间限1990年1月1日至2021年5月1日。
- 检索词包括「warfarin」「Chinese medicine」「traditional Chinese medicine」「Chinese patent medicine」等及其组合。
- 经筛选共获得64篇文献,包括临床报告、药理实验及体外实验。
主要发现
- 影响华法林抗凝效果的机制复杂,中药可通过多种机制增强和减弱华法林抗凝效果。
- 部分中药在体内和离体实验、药理学与临床研究中结果不一致,应成为未来研究重点。
临床怎么用
- 临床医生应了解与华法林相互作用的中药,联用时谨慎监测,避免不良临床治疗过程。
- 药师可参考中药影响华法林抗凝的机制,促进华法林安全合理使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Warfarin is a commonly used oral anticoagulant. It has a narrow therapeutic window and wide variation in individualized dosing, and is used clinically for the treatment of thromboembolic diseases. Due to the widespread use of traditional Chinese medicine (TCM) in China and the complex composition and diverse mechanisms of action of TCM, the combination of TCM and warfarin in patients has led to fluctuations in the international normalized ratio of warfarin or bleeding. To ensure rational clinical use, we summarize the TCMs with which warfarin interacts and the possible mechanisms, with a view to providing a clinical reference. Aim of the study: To summarize the mechanisms by which Chinese herbal medicines affect the enhancement or weakening of the anticoagulant effect of warfarin, to provide theoretical references for clinicians and pharmacists to use warfarin safely and rationally, and to avoid the adverse effects associated with the combination of Chinese herbal medicines and warfarin. Methods: A computerized literature search of electronic databases, including PubMed, MEDLINE, Cochrane Library, Web of Science (WOS), China National Knowledge Infrastructure (CNKI) and WANFANG Data was performed. Key words used in the literature search were "warfarin", "Chinese medicine", "traditional Chinese medicine", "Chinese patent medicine" etc. and their combinations in a time limit from January 1, 1990 to May 1, 2021. A total of 64 articles were obtained following the selection process, including clinical reports, pharmacological experiments and in vitro experiments which were reviewed to determine the mechanism of the anticoagulant effect of herbal medicine on warfarin. Results: The mechanisms affecting the anticoagulant effect of warfarin are complex, and herbal medicines may enhance and diminish the anticoagulant effect of warfarin through a variety of mechanisms; thus, clinical use needs to be cautious. Some herbal medicines have shown inconsistent results in both in vivo and ex vivo experiments, pharmacology and clinical studies, and should be the focus of future research. Conclusion: With the widespread use of TCM, the combination of warfarin and TCM is more common. This article will promote clinicians' knowledge and understanding of the TCMs which interact with warfarin, in order to avoid the occurrence of adverse clinical treatment processes, and improve the efficacy and safety.
引用
- Zhuang W, Liu S, Zhao X, et al. Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update. Front Pharmacol. 2021. PMID: 34616303. doi:10.3389/fphar.2021.751107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。